Free Access
Volume 55, Number 1, Mars 2020
Page(s) 51 - 54
Published online 03 January 2020
  • Bohn B et al. 2016. DPV Initiative. 20 years of pediatric benchmarking in Germany and Austria: Age-dependent analysis of longitudinal follow-up in 63 967 children and adolescents with type 1 diabetes. PLoSOne 11(8): e0160971. [CrossRef] [Google Scholar]
  • European Recommendation. 1999. Council of the European Union Recommendation on the limitation of exposure of the general public to electromagnetic fields (0 Hz to 300 GHz), 1999/519/EC, OJ. L 199/59. [Google Scholar]
  • Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. 2015. Insulin pump risks and benefits: A clinical appraisal of pump safety standards, adverse event reporting, and research needs. A Joint Statement of the European Association for the study of diabetes and the American Diabetes Association, Diabetes Technology Working Group. Diabetes Care 38: 716–722. [CrossRef] [PubMed] [Google Scholar]
  • International Commission on Non-Ionizing Radiation Protection (ICNIRP). 2010. Guidelines for limiting exposure to time-varying electric and magnetic fields (1 Hz–100 kHz). Health Phys. 99: 818–836. [PubMed] [Google Scholar]
  • Karges B et al. 2014. Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: A trend analysis in a cohort of 37 539 patients between 1995 and 2012. PloS Med. 11(10): e1001742. [CrossRef] [PubMed] [Google Scholar]
  • Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U, Boettcher C, Kapellen T, Rosenbauer J, Holl RW. 2017. Association of insulin pump therapy vs. insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA. 318(14): 1358–1366. [CrossRef] [PubMed] [Google Scholar]
  • Sherr JL, Hermann JM, Campbell F, Foster NC, Hofer SE, Allgrove J, Maahs DM, Kapellen TM, Holman N, Tamborlane WV, Holl RW, Beck RW, Warner JT. 2016. For the T1D Exchange Clinic Network, the DPV Initiative, and the National Paediatric Diabetes Audit and the Royal College of Paediatrics and Child Health registries, Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: Comparison of results from three large, transatlantic paediatric registries. Diabetologia 59: 87–91. [CrossRef] [PubMed] [Google Scholar]
  • Szypowska A, Schwandt A, Svensson J, Shalitin S, Cardona-Hernandez R, Forsander G, Sundberg F, De Beaufort C, Maahs D, Maffeis C, O’Riordan SM, Krisane ID, Scharf M, Castro S, Konstantinova M, Obermannova B, Casteels K, Gökşen D, Galhardo J, Kanaka-Gantenbein C, Rami-Merhar B, Madacsy L. 2016. SWEET Study Group. Insulin pump therapy in children with type 1 diabetes: Analysis of data from the SWEET registry. Pediatr. Diabetes 17(Suppl 23): 38–45. [CrossRef] [PubMed] [Google Scholar]
  • Zradziński P, Karpowicz J, Gryz K. 2018a. In silico modelling of influence from low or intermediate frequency magnetic fields on users of wearable insulin pumps. Int. J. Radiat. Biol. 94(10): 926–933. [CrossRef] [PubMed] [Google Scholar]
  • Zradziński P, Karpowicz J, Gryz K, Leszko W. 2018b. Evaluation of the safety of users of active implantable medical devices (AIMD) in the working environment in terms of exposure to electromagnetic fields – Practical approach to the requirements of European Directive 2013/35/EU. Int. J. Occup. Med. Environ. Health 31(6): 795–808. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.